Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02786498 · ClinicalTrials.gov registry record · Phase 2
Optimal Vitamin D3 Supplementation Strategies for Acute Fracture Healing
A Phase 2 study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- Phase 2
- Development phase
- 102
- Enrollment target
NCT02786498 is a Phase 2 study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 102 participants.
The verdict
NCT02786498, a Phase 2 study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 102 participants
- Enrollment target
Study Summary
The objective is to determine the effect of vitamin D3 supplementation on fracture healing at 3 months.
Interventions
- OTHER Placebo
- DRUG Vitamin D3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2016-11-21 |
| Est. Completion | 2021-12-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02786498
The ClinicalTrials.gov registry entry for NCT02786498 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02786498 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02786498 about?
NCT02786498 is a clinical study titled "Optimal Vitamin D3 Supplementation Strategies for Acute Fracture Healing". The objective is to determine the effect of vitamin D3 supplementation on fracture healing at 3 months.
What is the current status of trial NCT02786498?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 102 participants. The study started on 2016-11-21. Estimated completion is 2021-12-01.
What interventions are being tested in trial NCT02786498?
The interventions under investigation include: Placebo (OTHER), Vitamin D3 (DRUG).
Who is sponsoring clinical trial NCT02786498?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.